Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Crit Care Med. 2013 Nov;41(11):10.1097/CCM.0b013e31829860fc. doi: 10.1097/CCM.0b013e31829860fc

Table 5.

Comparison of the association between different AKI definitions and adverse outcomes in multivariable logistic regression models for training and validation cohorts

RIFLE-AKI Model
(compared to no RIFLE-AKI)
Percent change in sCr Model
(for every 10% change)
KDIGO-AKI Model
(compared to no KDIGO-AKI)
Absolute Change in sCr Model
(for every 0.1 mg/dl change)

Hospital mortality*
 OR (95% CI) 10.67 (8.59, 13.26) 1.05 (1.04, 1.06) 10.04 (7.94, 12.68) 1.08 (1.08, 1.09)
 Training AUC (95% CI) 0.84 (0.84, 0.86) 0.87 (0.86, 0.89) 0.84 (0.83, 0.85) 0.87 (0.87, 0.89)
 Validation AUC (95% CI) 0.86 (0.84, 0.88) 0.87 (0.87, 0.90) 0.85 (0.83, 0.88) 0.87 (0.85, 0.89)

90-day mortality*
 OR (95% CI) 3.26 (2.90, 3.67) 1.03 (1.03, 1.04) 2.94 (2.60, 3.33) 1.06 (1.06, 1.07)
 Training AUC (95% CI) 1 0.81 (0.80, 0.82) 0.82 (0.81, 0.83) 0.80 (0.79, 0.81) 0.82 (0.81, 0.83)
 Validation AUC (95% CI)1 0.84 (0.82, 0.86) 0.85 (0.83, 0.87) 0.83 (0.81, 0.86)** 0.85 (0.83, 0.87)

Sepsis*
 OR (95% CI) 15.97 (12.81, 19.91) 1.06 (1.05, 1.06) 15.49 (12.17, 19.72) 1.09 (1.08, 1.09)
 Training AUC (95% CI) 0.83 (0.83, 0.84) 0.87 (0.86, 0.88) 0.82 (0.81, 0.83) 0.84 (0.83, 0.86)
 Validation AUC (95% CI) 0.86 (0.85, 0.88)** 0.87 (0.85, 0.89) 0.85 (0.83, 0.87)** 0.85 (0.83, 0.87)

Severe sepsis*
 OR (95% CI) 31.02 (22.66, 42.47) 1.06 (1.05, 1.06) 30.84 (21.70, 43.84) 1.10 (1.09, 1.10)
 Training AUC (95% CI) 0.85 (0.84, 0.86) 0.89 (0.88, 0.9) 0.84 (0.83, 0.85) 0.87 (0.86, 0.88)
 Validation AUC (95% CI) 0.88 (0.86, 0.90)** 0.89 (0.86, 0.91) 0.87 (0.85, 0.88)** 0.87 (0.84, 0.89)

Postoperative surgical infection*
 OR (95% CI) 2.21 (1.97, 2.47) 1.02 (1.01, 1.02) 2.14 (1.91, 2.40) 1.03 (1.02,1.03)
 Training AUC (95% CI) 0.67 (0.66, 0.69) 0.66 (0.64, 0.67) 0.67 (0.65, 0.68) 0.65 (0.64, 0.67)
 Validation AUC (95% CI) 0.68 (0.65, 0.72) 0.67 (0.64, 0.7) 0.68 (0.65, 0.72) 0.67 (0.64, 0.7)

Mechanical wound complications*
 OR (95% CI) 2.39 (2.15, 2.66) 1.02 (1.01, 1.02) 2.26 (2.03, 2.51) 1.03 (1.02, 1.03)
 Training AUC (95% CI) 0.65 (0.65, 0.67) 0.63 (0.68, 0.65) 0.65 (0.64, 0.67) 0.63 (0.61, 0.64)
 Validation AUC (95% CI) 0.66 (0.63, 0.69) 0.64 (0.61, 0.67) 0.66 (0.63, 0.69) 0.64 (0.61, 0.67)

Procedural complications*
 OR (95% CI) 4.42 (4.13, 4.73) 1.02 (1.02, 1.02) 2.55 (2.30, 2.83) 1.03 (1.03, 1.04)
 Training AUC (95% CI) 0.65 (0.64, 0.66) 0.63 (0.61, 0.64) 0.65 (0.63, 0.66) 0.63 (0.61, 0.64)
 Validation AUC (95% CI) 0.68 (0.65, 0.71) 0.66 (0.63, 0.7) 0.68 (0.65, 0.72) 0.66 (0.63, 0.69)

Mechanical ventilation*
 OR (95% CI) 9.59 (8.58, 10.73) 1.06 (1.06, 1.06) 4.29 (4.01, 4.59) 1.09 (1.08, 1.09)
 Training AUC (95% CI) 0.82 (0.82, 0.83) 0.81 (0.81, 0.82) 0.82 (0.81, 0.82) 0.80 (0.80, 0.81)
 Validation AUC (95% CI) 0.84 (0.83, 0.85)** 0.84 (0.83, 0.85)** 0.83 (0.82, 0.84)** 0.82 (0.81, 0.83) **

Long term mechanical ventilation*
 OR (95% CI) 7.53 (6.67, 8.52) 1.06 (1.05, 1.06) 6.15 (5.43, 6.97) 1.08 (1.07, 1.08)
 Training AUC (95% CI) 0.81 (0.80, 0.82) 0.81 (0.80, 0.82) 0.79 (0.78, 0.80) 0.79 (0.77, 0.8)
 Validation AUC (95% CI) 0.83 (0.81, 0.85) 0.83 (0.81, 0.85) 0.81 (0.79, 0.83) 0.80 (0.78, 0.83)

Pulmonary complications*
 OR (95% CI) 3.85 (3.49, 4.23) 1.03 (1.02, 1.03) 3.68 (3.33, 4.07) 1.05 (1.04, 1.05)
 Training AUC (95% CI) 0.72 (0.71, 0.73) 0.70 (0.68, 0.71) 0.71 (0.70, 0.72) 0.69 (0.67, 0.70)
 Validation AUC (95% CI) 0.72 (0.70, 0.74) 0.70 (0.67, 0.72) 0.71 (0.69, 0.73) 0.69 (0.66, 0.71)

Cardiovascular complications*
 OR (95% CI) 2.24 (1.98, 2.53) 1.01 (1.01, 1.02) 2.38 (2.09, 2.70) 1.03 (1.02, 1.03)
 Training AUC (95% CI) 0.75 (0.73, 0.76) 0.74 (0.73, 0.75) 0.75 (0.74, 0.76) 0.74 (0.72, 0.75)
 Validation AUC (95% CI) 0.74 (0.72, 0.77) 0.74 (0.71, 0.76) 0.74 (0.71, 0.77) 0.74 (0.71, 0.76)

Neurological complications*
 OR (95% CI) 2.63 (2.21, 3.13) 1.02 (1.01, 1.02) 2.51 (2.11, 2.98) 1.04 (1.03, 1.04)
 Training AUC (95% CI) 0.85 (0.84, 0.87) 0.85 (0.84, 0.86) 0.85 (0.84, 0.87) 0.85 (0.84, 0.86)
 Validation AUC (95% CI) 0.86 (0.84, 0.89) 0.85 (0.82, 0.88) 0.86 (0.83, 0.89) 0.84 (0.82, 0.88)

GI complications*
 OR (95% CI) 2.56 (2.23, 2.94) 1.01 (1.01, 1.02) 2.51 (2.18, 2.89) 1.03 (1.02,1.04)
 Training AUC (95% CI) 0.75 (0.73, 0.76) 0.73 (0.71, 0.75) 0.75 (0.73, 0.76) 0.73 (0.71, 0.75)
 Validation AUC (95% CI) 0.78 (0.74, 0.81) 0.76 (0.73, 0.80) 0.78 (0.75, 0.81) 0.76 (0.73, 0.80)

For detailed models description see Statistical Analysis.

1

Training AUC (95% CI) and validation AUC (95% CI) indicate area under receiver operator curve with 95% confidence intervals for each model applied in training and validation cohort, respectively.

*

p-value < 0.05 for difference in AUC (95% CI) between the models fit for each listed AKI definition compared to NSQIP-AKI model.

**

p-value < 0.05 for difference in AUC (95% CI) between the models fit to training cohort and validation cohort.